Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00337532 | A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer | completed | Phase 2 / Phase 3 | 50 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00855764 | Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer | completed | Phase 2 | 36 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 4, 2010 | clinicaltrials |
| NCT00176748 | Treatment for Patients With Metastatic Thyroid Cancer | completed | Phase 2 | 3 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00268671 | Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) | completed | Phase 1 / Phase 2 | 45 | SanofiINDUSTRY | 0 | Dec 7, 2009 | clinicaltrials |
| NCT00521521 | Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer(TAX200006) | completed | Phase 2 | 86 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00006361 | SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00756951 | Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer(SCV-07 OM) | completed | Phase 2 | 59 | SciClone PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00436800 | Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00690872 | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer | unknown | Phase 2 | 35 | National Cancer Centre, SingaporeOTHER | 1 | Jun 29, 2009 | clinicaltrials |
| NCT00916097 | NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT) | completed | Phase 2 | 66 | SanofiINDUSTRY | 3 | Jun 24, 2009 | clinicaltrials |
| NCT00358930 | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 60 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00242749 | IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | completed | Phase 2 | 47 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00255476 | The IRESSA Novel Head and Neck Chemotherapy Evaluation Study | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00887107 | Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma | completed | Phase 2 | 32 | Leiden University Medical CenterOTHER | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00540332 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy | withdrawn | Phase 1 / Phase 2 | 0 | Swedish Orphan BiovitrumINDUSTRY | 0 | Mar 2, 2009 | clinicaltrials |
| NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | unknown | Phase 2 | — | Dana-Farber Cancer InstituteOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00167908 | Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer | completed | Phase 2 | 27 | Washington University School of MedicineOTHER | 0 | Feb 4, 2009 | clinicaltrials |
| NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)(TPF for NPC) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00817258 | Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | unknown | Phase 2 | 64 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | unknown | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00003327 | Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | unknown | Phase 2 | 60 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00697814 | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | completed | Phase 2 | 15 | Federal University of São PauloOTHER | 1 | Jun 16, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00001860 | Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | completed | Phase 2 | 5 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00080574 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | completed | Phase 2 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00611754 | Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 15 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00228488 | Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 2 | Dec 19, 2007 | clinicaltrials |
| NCT00239304 | Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00180921 | Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck | unknown | Phase 2 | 30 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00195078 | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 29 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00116909 | A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy | completed | Phase 2 | 85 | OSI PharmaceuticalsINDUSTRY | 1 | Mar 14, 2007 | clinicaltrials |
| NCT00230191 | Safety and Efficacy of RK0202 in Oral Mucositis | completed | Phase 2 | 110 | RxKinetixINDUSTRY | 2 | Jan 15, 2007 | clinicaltrials |
| NCT00251381 | Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. | unknown | Phase 2 | 90 | Trial Form Support S.L.OTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00026975 | Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Feb 26, 2010source: clinicaltrials